PL3979982T3 - Kompozycja zawierająca bakteryjny szczep lactobacillus paracasei i kwas hialuronowy oraz jej zastosowanie do leczenia skóry - Google Patents

Kompozycja zawierająca bakteryjny szczep lactobacillus paracasei i kwas hialuronowy oraz jej zastosowanie do leczenia skóry

Info

Publication number: PL3979982T3
Authority: PL; Poland
Prior art keywords: skin; compositions; treatment; hyaluronic acid; bacterial strain
Prior art date: 2019-06-05

Application number

PL20736427.4T

Other languages

English (en)

Inventor

Andrea BIFFI

Original Assignee

Lac2biome S.r.l.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2019-06-05

Filing date

2020-06-05

Publication date

2023-08-07

2020-06-05 Application filed by Lac2biome S.r.l. filed Critical Lac2biome S.r.l.

2023-08-07 Publication of PL3979982T3 publication Critical patent/PL3979982T3/pl

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
241000186605 Lactobacillus paracasei Species 0.000 title 1
230000001580 bacterial effect Effects 0.000 title 1
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Birds (AREA)
Biotechnology (AREA)
Tropical Medicine & Parasitology (AREA)
Gerontology & Geriatric Medicine (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Immunology (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Polymers & Plastics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Virology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL20736427.4T 2019-06-05 2020-06-05 Kompozycja zawierająca bakteryjny szczep lactobacillus paracasei i kwas hialuronowy oraz jej zastosowanie do leczenia skóry PL3979982T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT201900008097		2019-06-05
PCT/IB2020/055326 WO2020245797A1 (en)	2019-06-05	2020-06-05	Compositions comprising a bacterial strain lactobacillus paracasei and hyaluronic acid and the use thereof for the treatment of the skin

Publications (1)

Publication Number	Publication Date
PL3979982T3 true PL3979982T3 (pl)	2023-08-07

Family

ID=68073033

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL20736427.4T PL3979982T3 (pl)	2019-06-05	2020-06-05	Kompozycja zawierająca bakteryjny szczep lactobacillus paracasei i kwas hialuronowy oraz jej zastosowanie do leczenia skóry

Country Status (16)

Country	Link
US (1)	US20220313757A1 (pl)
EP (1)	EP3979982B1 (pl)
JP (2)	JP7680376B2 (pl)
KR (1)	KR102915719B1 (pl)
CN (1)	CN114025778B (pl)
AU (1)	AU2020287268B2 (pl)
BR (1)	BR112021023340A2 (pl)
CA (1)	CA3142566A1 (pl)
DK (1)	DK3979982T3 (pl)
ES (1)	ES2947484T3 (pl)
MA (1)	MA56107A (pl)
MX (1)	MX2021014633A (pl)
PL (1)	PL3979982T3 (pl)
UA (1)	UA130768C2 (pl)
WO (1)	WO2020245797A1 (pl)
ZA (1)	ZA202109421B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN112870148B (zh) *	2021-01-18	2023-04-07	广东轻工职业技术学院	一种基于牵引结构的微生态平衡的益生素微球的制备方法
WO2022157307A1 (en) *	2021-01-22	2022-07-28	Dsm Ip Assets B.V.	Hyaluronic acid as antimicrobial agent for use on the skin
CN112940968B (zh) *	2021-02-07	2022-07-01	山东凤凰生物科技股份有限公司	一种发酵乳杆菌、发酵乳杆菌的培养物及其制备方法
JP7594980B2 (ja) *	2021-06-22	2024-12-05	株式会社ヤクルト本社	単純ヘルペスウイルスの再活性化抑制用組成物
IT202100017855A1 (it) *	2021-07-06	2023-01-06	Lac2Biome S R L	Bacteria strains for topical skin care
CN114703079B (zh) *	2021-09-08	2023-05-26	青岛蔚蓝生物股份有限公司	一株副干酪乳杆菌及其在缓解皮肤损伤中的应用
EP4440543A1 (en) *	2021-11-30	2024-10-09	International N&H Denmark ApS	Lactobacilli for skin aging
KR102739246B1 (ko) *	2022-02-11	2024-12-06	주식회사 잇츠한불	락토바실러스 균주 혼합물을 유효성분으로 포함하는 피부 보호용 조성물
CN116762959B (zh) *	2022-03-11	2025-04-18	青岛蔚蓝生物股份有限公司	一种副干酪乳酪杆菌微胶囊及其制备方法和应用
IT202200014323A1 (it) *	2022-07-06	2024-01-06	Lac2Biome S R L	Ceppi di batteri per la cura topica della pelle
CN115044519B (zh) *	2022-08-12	2022-10-25	山东锦鲤生物工程有限公司	解淀粉乳杆菌及其应用
KR102485314B1 (ko) *	2022-09-22	2023-01-09	주식회사 에이바이오머티리얼즈	유산균 발효 시어버터와 유산균 발효 시어버터 배양액 유래 엑소좀의 복합물을 유효성분으로 함유하는 화장료 조성물
CN118356464A (zh) *	2023-01-19	2024-07-19	百岳特生物技术（上海）有限公司	黑青稞萃取物用于调节免疫力的用途
CN117625454B (zh) *	2023-11-22	2026-02-27	江南大学	一株有抗糖化抗衰功能的副干酪乳酪杆菌ccfm1355及其后生元
CN117721036A (zh) *	2023-11-22	2024-03-19	江南大学	一株调控Wnt/β-catenin通路防脱的副干酪乳酪杆菌CCFM1350及其后生元
WO2025128710A2 (en) *	2023-12-11	2025-06-19	University Of South Florida	Bacterial strains for skin health
EP4635475A1 (en) *	2024-04-15	2025-10-22	CLR-Chemisches Laboratorium Dr. Kurt Richter GmbH	Cosmetical composition comprising bacterial components
EP4722390A1 (fr) *	2024-10-04	2026-04-08	Laboratoires M & L	Bacterie du genre brevundimonas et ses utilisations cosmetiques
KR102851445B1 (ko) *	2024-12-27	2025-08-28	(주)에이스바이옴	락티카제이바실러스 파라카제이 아종 파라카제이 abf21013를 포함하는 피부노화 예방 또는 개선용 조성물
CN119842565B (zh) *	2025-03-18	2025-08-22	东北农业大学	一株副干酪乳杆菌及其在抗衰老和抗糖化中的应用
KR102866782B1 (ko) *	2025-07-31	2025-10-01	주식회사 일진코스메틱	버섯 5종 추출 배양액을 포함하는 자생력 증진, 보습, 미백 및 항산화용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0517363A (ja) *	1991-07-11	1993-01-26	Yakult Honsha Co Ltd	抗炎症剤及びそれを含有する化粧料
JP4010574B2 (ja) *	1994-12-05	2007-11-21	電気化学工業株式会社	皮膚外用剤
KR101449687B1 (ko)	2008-03-13	2014-10-14	주식회사 바이오랜드	저분자 및 고분자 히알루론산과 유근피로부터 분리된다당체 추출물을 함유하는 노화방지용 조성물
JP2010173991A (ja)	2009-01-30	2010-08-12	Kouai Kagaku Co Ltd	皮膚外用剤
FR2942719B1 (fr) *	2009-03-04	2011-08-19	Oreal	Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
KR20140127437A (ko) *	2013-04-24	2014-11-04	학교법인연세대학교	락토바실러스 파라카제이 ｍｋ１을 이용한 주름개선용 화장료 조성물 및 그 제조방법
KR20150087634A (ko)	2014-01-22	2015-07-30	주식회사한국야쿠르트	여드름 원인균 프로피오니박테리움 아크네스의 생장억제 효능을 가지는 락토바실러스 파라카제이 hy7301 및 이를 유효성분으로 함유하는 제품
TWM483083U (zh) *	2014-03-13	2014-08-01	Shiteh Organic Pharmaceutical Co Ltd	一種乳酸菌結合有機植物萃取可用於治療與預防異位性皮膚炎、濕疹、汗疹、小兒尿布疹與青春痘等皮膚炎之雙球體微脂粒結構。
MA39710A (fr)	2014-04-23	2015-10-29	Sofar Spa	Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
KR20160092569A (ko) *	2015-01-27	2016-08-05	인코스(주)	효모, 유산균 2단 발효 추출물을 함유하는 항산화, 주름개선, 보습 효과를 갖는 화장료 조성물
KR101764412B1 (ko)	2015-09-14	2017-08-14	일동바이오사이언스(주)	기능성 수화 히알루론산 및 이를 이용한 장 점막부착능이 우수하고 선택적 길항작용을 하는 코팅 유산균의 제조방법
WO2017195182A1 (en) *	2016-05-13	2017-11-16	Sofar S.P.A.	Use of probiotics for improving protein absorption
IT201600122724A1 (it) *	2016-12-02	2018-06-02	Sofar Spa	Exopolysaccharides and uses thereof
CN106902073A (zh) *	2017-01-19	2017-06-30	长沙协浩吉生物工程有限公司	一种酵素抗衰老精华液的配制方法
JP7208894B2 (ja) *	2017-05-23	2023-01-19	森永乳業株式会社	乳酸菌を含有する化粧料、皮膚保護剤
IT201700101704A1 (it) *	2017-09-12	2019-03-12	Sofar Spa	Nuovo uso per trattamento delle infezioni da clostridium difficile
ES3049515T3 (en) *	2017-12-06	2025-12-17	Lac2Biome S R L	Composition based on probiotics and uses thereof

2020
- 2020-06-05 DK DK20736427.4T patent/DK3979982T3/da active
- 2020-06-05 ES ES20736427T patent/ES2947484T3/es active Active
- 2020-06-05 AU AU2020287268A patent/AU2020287268B2/en active Active
- 2020-06-05 BR BR112021023340A patent/BR112021023340A2/pt active IP Right Grant
- 2020-06-05 PL PL20736427.4T patent/PL3979982T3/pl unknown
- 2020-06-05 CA CA3142566A patent/CA3142566A1/en active Pending
- 2020-06-05 JP JP2021572311A patent/JP7680376B2/ja active Active
- 2020-06-05 WO PCT/IB2020/055326 patent/WO2020245797A1/en not_active Ceased
- 2020-06-05 KR KR1020227000365A patent/KR102915719B1/ko active Active
- 2020-06-05 MX MX2021014633A patent/MX2021014633A/es unknown
- 2020-06-05 US US17/616,589 patent/US20220313757A1/en active Pending
- 2020-06-05 MA MA056107A patent/MA56107A/fr unknown
- 2020-06-05 CN CN202080041816.2A patent/CN114025778B/zh active Active
- 2020-06-05 EP EP20736427.4A patent/EP3979982B1/en active Active
- 2020-06-05 UA UAA202107339A patent/UA130768C2/uk unknown
2021
- 2021-11-23 ZA ZA2021/09421A patent/ZA202109421B/en unknown
2025
- 2025-05-08 JP JP2025077774A patent/JP2025121990A/ja active Pending

Also Published As

Publication number	Publication date
MX2021014633A (es)	2022-02-11
EP3979982A1 (en)	2022-04-13
JP7680376B2 (ja)	2025-05-20
WO2020245797A1 (en)	2020-12-10
EP3979982B1 (en)	2023-04-05
ZA202109421B (en)	2023-06-28
AU2020287268A1 (en)	2022-01-06
JP2022535875A (ja)	2022-08-10
CA3142566A1 (en)	2020-12-10
CN114025778B (zh)	2024-04-12
UA130768C2 (uk)	2026-05-13
AU2020287268B2 (en)	2026-02-19
US20220313757A1 (en)	2022-10-06
KR20220016983A (ko)	2022-02-10
JP2025121990A (ja)	2025-08-20
MA56107A (fr)	2022-04-13
ES2947484T3 (es)	2023-08-10
DK3979982T3 (da)	2023-07-03
KR102915719B1 (ko)	2026-01-20
BR112021023340A2 (pt)	2022-04-12
CN114025778A (zh)	2022-02-08

Publication	Publication Date	Title
ZA202109421B (en)	2023-06-28	Compositions comprising a bacterial strain lactobacillus paracasei and hyaluronic acid and the use thereof for the treatment of the skin
SG11202010944RA (en)	2020-12-30	Lactobacillus paracasei strain and use thereof
EP4086336A4 (en)	2023-10-11	STRAIN OF LACTOBACILLUS PLANTARUM, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLIC DISEASES CONTAINING SAME
AU2021350460A9 (en)	2024-10-31	Novel lactic acid bacteria and use thereof
EP4219680A4 (en)	2024-08-28	NOVEL LACTIC ACID BACTERIA AND THEIR USE
EP4086334A4 (en)	2023-10-11	LACTOBACILLUS FERMENTUM STRAIN AND COMPOSITION THEREOF FOR PREVENTING OR TREATING METABOLIC DISEASES
EP4364745A3 (en)	2024-07-17	Novel lactic acid bacteria and use thereof
EP3798298A4 (en)	2022-05-11	LACTOBACILLUS GASSERI KBL697 STRAIN AND ITS USE
EP4086335A4 (en)	2023-10-11	LACTOBACILLUS FERMENTUM STRAIN, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLIC DISEASES, INCLUDING THE SAME
NZ715667A (en)	2022-02-25	Oral compositions
ZA201804863B (en)	2022-03-30	Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
EP3641568C0 (en)	2026-01-28	Composition with bacterial strains of the genus Lactobacillus salivarius for the treatment of Parkinson's disease
GB2615478B (en)	2023-12-06	Therapeutic and prophylactic use of microorganisms
WO2019098810A3 (ko)	2019-07-18	신규 유산균 및 이의 용도
GB2549400A (en)	2017-10-18	Creped prebiotic tissue
GB201610052D0 (en)	2016-07-27	Use of a heat-inactivated lactobacillus strain and composition for inhibiting bacterial adhesion of oral pathogens
EP2582851B8 (en)	2015-01-07	New strain of lactobacillus plantarum s, the use of the strain of lactobacillus plantarum s and the preparation for roughages ensiling
ZA202110015B (en)	2022-03-30	New pseudoxanthomonas beigongshangensis strain and use thereof
PT3741218T (pt)	2025-07-11	Estirpe de lactobacillus salivarus e seu uso na prevenção e tratamento de diarreia pós-desmame em leitões
HK40072415B (en)	2023-11-17	Compositions comprising a bacterial strain lactobacillus paracasei and hyaluronic acid and the use thereof for the treatment of the skin
HK40072415A (en)	2022-11-25	Compositions comprising a bacterial strain lactobacillus paracasei and hyaluronic acid and the use thereof for the treatment of the skin
WO2014096083A3 (fr)	2014-11-13	Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine
MX2020013860A (es)	2021-03-25	Composiciones probioticas y sus usos.
EP4375365A4 (en)	2025-03-26	NOVEL STRAIN OR COMPOSITION OF LACTOBACILLUS PARACASEI ATG-E1 COMPRISING SAME FOR PREVENTING OR TREATING RESPIRATORY DISEASE
PT3517119T (pt)	2021-11-30	Composição compreendendo nova estirpe de lactobacillus salivarius e método para a prevenção e tratamento de otite e infeções respiratórias superiores